Welcome to LookChem.com Sign In|Join Free
  • or
C34H54O5Si is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1209385-74-9

Post Buying Request

1209385-74-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1209385-74-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1209385-74-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,9,3,8 and 5 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1209385-74:
(9*1)+(8*2)+(7*0)+(6*9)+(5*3)+(4*8)+(3*5)+(2*7)+(1*4)=159
159 % 10 = 9
So 1209385-74-9 is a valid CAS Registry Number.

1209385-74-9Relevant academic research and scientific papers

Total synthesis of (+)-irciniastatin A (a.k.a. psymberin) and (-)-irciniastatin B

An, Chihui,Jurica, Jon A.,Walsh, Shawn P.,Hoye, Adam T.,Smith, Amos B.

, p. 4278 - 4296 (2013/06/27)

A unified synthetic strategy to access (+)-irciniastatin A (a.k.a. psymberin) and (-)-irciniastatin B, two cytotoxic secondary metabolites, has been achieved. Highlights of the convergent strategy comprise a boron-mediated aldol union to set the C(15)-C(17) syn-syn triad, reagent control to set the four stereocenters of the tetrahydropyran core, and a late-stage Curtius rearrangement to install the acid-sensitive stereogenic N,O-aminal. Having achieved the total synthesis of (+)-irciniastatin A, we devised an improved synthetic route to the tetrahydropyran core (13 steps) compared to the first-generation synthesis (22 steps). Construction of the structurally similar (-)-irciniastatin B was then achieved via modification of a late-stage (-)-irciniastatin A intermediate to implement a chemoselective deprotection/oxidation sequence to access the requisite oxidation state at C(11) of the tetrahydropyran core. Of particular significance, the unified strategy will permit late-stage diversification for analogue development, designed to explore the biological role of substitution at the C(11) position of these highly potent tumor cell growth inhibitory molecules.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1209385-74-9